Personality and inflammation: The protective effect of openness to experience

Ethnicity and Disease

Volumn 20, Issue 1, 2010, Pages 11-14

  Jonassaint, Charles R ^a   Boyle, Stephen H ^a   Kuhn, Cynthia M ^a   Siegler, Ilene C ^a   Copeland, William E ^a   Williams, Redford ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Coronary heart disease; Openness to experience

Indexed keywords

C REACTIVE PROTEIN;

AGE DISTRIBUTION; ANALYSIS OF COVARIANCE; ARTICLE; BLOOD SAMPLING; BODY MASS; CAUCASIAN; CLINICAL PROTOCOL; COMMUNITY ASSESSMENT; CONTROLLED STUDY; EDUCATIONAL STATUS; EMOTION; ESTHETICS; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; MENTAL STRESS; NEGRO; NORMAL HUMAN; OPENNESS TO EXPERIENCE DOMAIN; PARTICIPANT OBSERVATION; PERSONAL EXPERIENCE; PERSONALITY; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL MODEL; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE; SOCIAL INTERACTION; THINKING; TIME; VOLUNTEER; AFRICAN AMERICAN; BLOOD; ETHNOLOGY; METABOLISM; PSYCHOLOGICAL ASPECT;

AFRICAN AMERICANS; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFLAMMATION; MALE; PERSONALITY; STRESS, PSYCHOLOGICAL;

EID: 77951639030     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa, Fl: Psychological Assessment Resources; 1992.
2. Jonassaint CR, Boyle SH, Williams RB, Mark DB, Siegler IC, Barefoot JC. Facets of openness predict mortality in patients with cardiac disease. Psychosom Med. 2007;69:319-22.
3. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419-20.
4. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25:2016-21. (Pubitemid 41071061)
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.
6. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-9.
7. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 2001;19:857-61.
8. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945-51.
9. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477-82. (Pubitemid 28228207)
10. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326-33.
11. Michowitz Y, Arbel Y, Wexler D, et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol. 2008;125:347-51.
12. Alizadeh Dehnavi R, de Roos A, Rabelink TJ, et al. Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity. Atherosclerosis. 2008;200(2):417-23.
13. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
14. Suarez EC. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med. 2004;66:684-91.
15. Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R. Hostility and pain are related to inflammation in older adults. Brain Behav Immun. 2006;20:389-400.
16. Coccaro EF. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res. 2006;40:460-5.
17. Burroughs AR, Visscher WA, Haney TL, et al. Community recruitment process by race, gender, and SES gradient: lessons learned from the Community Health and Stress Evaluation (CHASE) Study experience. J Community Health. 2003;28:421-37.
18. Surwit RS, Williams RB, Siegler IC, et al. Hostility, race, and glucose metabolism in nondiabetic individuals. Diabetes Care. 2002;25:835-9.
19. Williams RB, Barefoot JC, Schneiderman N. Psychosocial risk factors for cardiovascular disease: more than one culprit at work. JAMA. 2003;290:2190-2. (Pubitemid 37432979)
20. Williams RB, Marchuk DA, Gadde KM, et al. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med. 2001;63:300-5.
21. Lane RD, Sechrest L, Riedel R, Shapiro DE, Kaszniak AW. Pervasive emotion recognition deficit common to alexithymia and the repressive coping style. Psychosom Med. 2000;62:492-501.
22. Lumley MA, Stettner L, Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res. 1996;41:505-18.
23. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901-12.
24. Taylor GJ, Bagby RM, Parker JD. The alexithymia construct. A potential paradigm for psychosomatic medicine. Psychosomatics. 1991;32:153-64.
25. Kauhanen J, Kaplan GA, Julkunen J, Wilson TW, Salonen JT. Social factors in alexithymia. Compr Psychiatry. 1993;34:330-5.
26. Kauhanen J, Julkunen J, Salonen JT. Coping with inner feelings and stress: heavy alcohol use in the context of alexithymia. Behav Med. 1992;18:121-6.
27. Hendryx MS, Haviland MG, Shaw DG. Dimensions of alexithymia and their relationships to anxiety and depression. J Pers Assess. 1991;56:227-37.
28. Williams DR. Race and health: basic questions, emerging directions. Ann Epidemiol. 1997;7:322-33.
29. Boyle SH, Surwit RS, Georgiades A, et al. Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator. Diabetes Care. 2007;30:2484-8.